000			02130nam a22004455i 4500
001			978-3-7091-0356-2
003			DE-He213
005			20140220083818.0
007			cr nn 008mamaa
008			101201s2011 au | s |||| 0|eng d
020			_a9783709103562 _9978-3-7091-0356-2
024	7		_a10.1007/978-3-7091-0356-2 _2doi
050		4	_aRD592.5-596
072		7	_aMNN _2bicssc
072		7	_aMED085010 _2bisacsh
082	0	4	_a617.48 _223
100	1		_aFeng, Hua. _eeditor.
245	1	0	_aEarly Brain Injury or Cerebral Vasospasm _h[electronic resource] : _bVolume 2: Clinical Management / _cedited by Hua Feng, Ying Mao, John H. Zhang.
264		1	_aVienna : _bSpringer Vienna : _bImprint: Springer, _c2011.
300			_aXII, 264p. 82 illus., 2 illus. in color. _bonline resource.
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
347			_atext file _bPDF _2rda
490	1		_aActa Neurochirurgica Supplements, _x0065-1419 ; _v110/2
520			_aMore than 40 articles provide an extensive coverage of advances over the last three years of research on clinical management of subarachnoid hemorrhage. Novel experimental treatment strategies for early brain injury and cerebral vasospasm targeting genetic, molecular, and protein signaling pathways in preclinical models; surgical and endovascular treatment promote collaborative efforts from neurosurgery, neurology, radiology and neuro-ICU; advancement of neuroimaging provides guidance for new treatment strategies to reduce early brain injury and attenuate cerebral vasospasm.
650		0	_aMedicine.
650		0	_aNeurosurgery.
650	1	4	_aMedicine & Public Health.
650	2	4	_aNeurosurgery.
700	1		_aMao, Ying. _eeditor.
700	1		_aZhang, John H. _eeditor.
710	2		_aSpringerLink (Online service)
773	0		_tSpringer eBooks
776	0	8	_iPrinted edition: _z9783709103555
830		0	_aActa Neurochirurgica Supplements, _x0065-1419 ; _v110/2
856	4	0	_uhttp://dx.doi.org/10.1007/978-3-7091-0356-2
912			_aZDB-2-SME
999			_c108669 _d108669